rifabutin

Pre-clinicalCompleted

0 watching 0 views this week💤 Quiet

Hype Score

Development Stage

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Tuberculosis

Conditions

Tuberculosis, Non-tuberculous Mycobacterial Diseases (Including MAC Disease)

Trial Timeline

Nov 1, 2008 → Jul 1, 2016

NCT ID

NCT00810407

About rifabutin

rifabutin is a pre-clinical stage product being developed by Pfizer for Tuberculosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00810407. Target conditions include Tuberculosis, Non-tuberculous Mycobacterial Diseases (Including MAC Disease).

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (3)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00810446	Pre-clinical	Completed	Jun 1, 2009	Mar 1, 2018	Non-tuberculous Mycobacterial Diseases
NCT00810407	Pre-clinical	Completed	Nov 1, 2008	Jul 1, 2016	Tuberculosis
NCT03164291	Phase 3	Completed	Jun 1, 1984	May 18, 2017	Nontuberculous Mycobacterial Infections

Competing Products

20 competing products in Tuberculosis

See all competitors

Product	Company	Stage	Hype Score
GSK1349572 + Placebo + Iohexol Injection + Para-aminohippurate infusion	Shionogi	Phase 1	33
BCG Vaccine USP + Isoniazid + Rifampin	Merck	Phase 1	33
MK-7762 (TBD09)	Merck	Phase 1	33
Doravirine (DOR) + Rifapentine (RPT) + Isoniazid (INH)	Merck	Phase 1	33
Indacaterol + Control	Novartis	Phase 3	77
Ag85B-ESAT6 fusion protein H1 + Ag85B-ESAT6 fusion protein H1 + Ag85B-ESAT6 fusion protein H1 + Ag85B-ESAT6 fusion protein H1 + Ag85B-ESAT6 fusion protein H1 + Ag85B-ESAT6 fusion protein H1	Novartis	Phase 1	33
Delamanid + Levofloxacin + Bedaquiline + Clofazimine + Linezolid	Novartis	Phase 2	52
Rifampicin + Isoniazid + Pyrazinamide + Kanamycin + Moxifloxacin	Novartis	Phase 1	33
Rifapentine daily + Rifapentine weekly	Gilead Sciences	Approved	84
Linezolid + Ethambutol	Pfizer	Phase 2	51
Myrin© 2 (Rifampicin + Isoniazid) + Rimactane® (Rifampicin)	Pfizer	Phase 1	32
Azacitidine Injection	Bristol Myers Squibb	Phase 1/2	40
Rifapentine + Isoniazid	Sanofi	Phase 1/2	40
AERAS-404 + Placebo + Bacillus Calmette-Guérin (BCG)	Sanofi	Phase 2	51
rifampin + rifapentine + rifapentine + rifapentine	Sanofi	Phase 2	51
rifapentine (M000473) + EFZ EMT TDF	Sanofi	Phase 1	32
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide & Rifampicin	Sanofi	Phase 3	76
Rifampicin in higher doses	Sanofi	Phase 2	51
Higher-Dose Rifampin	Sanofi	Phase 2	51
Rifampin & midazolam + rifapentine & midazolam + rifapentine & midazolam + rifapentine & midazolam + rifapentine and midazolam + rifapentine and midazolam	Sanofi	Phase 1	32

Other Products from Pfizer